Vir Biotechnology Inc (VIR)
8.23
+0.60
(+7.86%)
USD |
NASDAQ |
Apr 26, 16:00
8.21
-0.02
(-0.24%)
After-Hours: 20:00
Vir Biotechnology Market Cap: 1.111B for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 26, 2024 | 1.111B |
| April 25, 2024 | 1.030B |
| April 24, 2024 | 1.086B |
| April 23, 2024 | 1.098B |
| April 22, 2024 | 1.094B |
| April 19, 2024 | 1.074B |
| April 18, 2024 | 1.075B |
| April 17, 2024 | 1.114B |
| April 16, 2024 | 1.129B |
| April 15, 2024 | 1.157B |
| April 12, 2024 | 1.211B |
| April 11, 2024 | 1.248B |
| April 10, 2024 | 1.227B |
| April 09, 2024 | 1.287B |
| April 08, 2024 | 1.281B |
| April 05, 2024 | 1.261B |
| April 04, 2024 | 1.279B |
| April 03, 2024 | 1.308B |
| April 02, 2024 | 1.299B |
| April 01, 2024 | 1.377B |
| March 28, 2024 | 1.368B |
| March 27, 2024 | 1.364B |
| March 26, 2024 | 1.346B |
| March 25, 2024 | 1.350B |
| March 22, 2024 | 1.357B |
| Date | Value |
|---|---|
| March 21, 2024 | 1.362B |
| March 20, 2024 | 1.373B |
| March 19, 2024 | 1.350B |
| March 18, 2024 | 1.442B |
| March 15, 2024 | 1.453B |
| March 14, 2024 | 1.421B |
| March 13, 2024 | 1.479B |
| March 12, 2024 | 1.449B |
| March 11, 2024 | 1.539B |
| March 08, 2024 | 1.534B |
| March 07, 2024 | 1.520B |
| March 06, 2024 | 1.475B |
| March 05, 2024 | 1.469B |
| March 04, 2024 | 1.511B |
| March 01, 2024 | 1.518B |
| February 29, 2024 | 1.518B |
| February 28, 2024 | 1.566B |
| February 27, 2024 | 1.543B |
| February 26, 2024 | 1.607B |
| February 23, 2024 | 1.557B |
| February 22, 2024 | 1.391B |
| February 21, 2024 | 1.365B |
| February 20, 2024 | 1.381B |
| February 16, 2024 | 1.384B |
| February 15, 2024 | 1.390B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.030B
Minimum
Apr 25 2024
10.58B
Maximum
Jan 27 2021
3.656B
Average
3.480B
Median
Apr 21 2023
Market Cap Benchmarks
| Vertex Pharmaceuticals Inc | 102.67B |
| Vistagen Therapeutics Inc | 128.37M |
| Immuneering Corp | 43.59M |
| SeaStar Medical Holding Corp | 33.20M |
| NovaBay Pharmaceuticals Inc | 2.372M |
Market Cap Related Metrics
| PS Ratio | 27.95 |
| Price to Book Value | 0.6988 |
| Price | 8.23 |
| Earnings Yield | -55.77% |